Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weiner

Showing results (371-380 of 380) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 380 results.
Nature Medicine|April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedoniaAndrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Science Immunology|June 7, 2024
Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cellsBenjamin Y Winer, Alexander H Settle, Alexandrina M Yakimov, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Plasma membrane abundance dictates phagocytic capacity and functional crosstalk in myeloid cellsBenjamin Y Winer, Alexander H Settle, Alexandrina M Yakimov, et al.
The American Journal of Psychiatry|July 16, 2016
Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE StudyCharles H Kellner, Mustafa M Husain, Rebecca G Knapp, et al.
The American Journal of Psychiatry|July 16, 2016
A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE StudyCharles H Kellner, Mustafa M Husain, Rebecca G Knapp, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 13, 2020
Indications for and Findings on Transthoracic Echocardiography in COVID-19Sneha S Jain, Qi Liu, Jayant Raikhelkar, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 11, 2019
Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE StudySarah H Lisanby, Shawn M McClintock, George Alexopoulos, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 2, 2021
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE StudySarah H Lisanby, Shawn M McClintock, William V McCall, et al.
The Journal of ECT|June 15, 2022
National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive TherapyPeter P Zandi, Michael Morreale, Irving M Reti, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Pageof 38

Showing results (371-380 of 380) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 380 results.
Nature Medicine|April 2, 2020
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedoniaAndrew D Krystal, Diego A Pizzagalli, Moria Smoski, et al.
Science Immunology|June 7, 2024
Plasma membrane abundance dictates phagocytic capacity and functional cross-talk in myeloid cellsBenjamin Y Winer, Alexander H Settle, Alexandrina M Yakimov, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Plasma membrane abundance dictates phagocytic capacity and functional crosstalk in myeloid cellsBenjamin Y Winer, Alexander H Settle, Alexandrina M Yakimov, et al.
The American Journal of Psychiatry|July 16, 2016
Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE StudyCharles H Kellner, Mustafa M Husain, Rebecca G Knapp, et al.
The American Journal of Psychiatry|July 16, 2016
A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE StudyCharles H Kellner, Mustafa M Husain, Rebecca G Knapp, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 13, 2020
Indications for and Findings on Transthoracic Echocardiography in COVID-19Sneha S Jain, Qi Liu, Jayant Raikhelkar, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 11, 2019
Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE StudySarah H Lisanby, Shawn M McClintock, George Alexopoulos, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 2, 2021
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE StudySarah H Lisanby, Shawn M McClintock, William V McCall, et al.
The Journal of ECT|June 15, 2022
National Network of Depression Centers' Recommendations on Harmonizing Clinical Documentation of Electroconvulsive TherapyPeter P Zandi, Michael Morreale, Irving M Reti, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Pageof 38